Low-income breast cancer patients skipping hormonal therapy, increasing their risks

Many low-income women are failing to take the hormonal therapy prescribed as part of their breast cancer treatment, possibly lowering their survival rates, according to a study led by a researcher in the Duke Comprehensive Cancer Center.

If you want to include this story in your blog, copy and paste this formatted text: